Kevin Dolgin

Kevin Dolgin

Kevin Dolgin's picture
Kevin Dolgin has worked as a senior international consultant in marketing and strategy for the pharmaceutical industry for over 20 years. He is also an Associate Professor in management at Université de Paris I. Before Observia, he created the Areks, now part of IMS Health. He has an undergraduate degree from Fordham University, an MBA from INSEAD and a Master of Research from the Sorbonne. Observia is one of Europe’s foremost companies in the domain of adherence, focusing on digital health programs to improve patient outcomes. Observia’s mission is to help chronic patients adhere to the treatment given by their healthcare professional.

Latest posts from Kevin:


Service with a Smile

Jul 29, 2013

This month Kevin Dolgin explains some of the oft-overlooked truths behind...


Putting Patients Second

Jun 20, 2013

Kevin Dolgin shines a light on the current industry trend of 'putting...


Listen to ALL of Your Customers!

May 24, 2013

Kevin Dolgin explains the importance of listening to all of your customer...


Patient Services: We Have Nothing...

Apr 16, 2013

Kevin Dolgin examines the current reluctant attitude towards heavy investment...


P Number Two

Feb 19, 2013

Before we dive with a solid splash into the sea of patient considerations,...


2013: A Very New Year

Jan 15, 2013

Before jumping back into whatever overall narrative thread I was planning on...



Dec 18, 2012

This month Kevin Dolgin discusses pharma's innate fear of complexity, and...


P #1: “The Payer”

Nov 21, 2012

In the first of Kevin's four-part "P" series, he talks to Peder...


Don't Ignore the Four Ps

Oct 19, 2012

Evolving sales trends and attitudes towards common business practices have...


The CLM Revolution Still Needs The...

Oct 1, 2012

With the introduction of tablet computing and the adoption of closed loop...